Table 2.
Distribution of individual comorbidities according to age class (counting multiple comorbidities on the same individuals). Percentages are calculated for each single comorbidity on the total number of subjects in the age class. (ATS of Milan, 2021).
| 16–65 |
65–79 |
80+ |
Overall | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dead | Alive | Dead | Alive | Dead | Alive | |||||||
| 693 | 114,422 | 2,782 | 17,072 | 4,192 | 6,926 | 146,087 | ||||||
| N. | N. (%) | N. (%) | N.(%) | N.(%) | N. (%) | N. | % | |||||
| C56 | Hypertension | 290 (41.8) | 12,219 (10.7) | 1,875 (67.4) | 9,567 (56.0) | 3,178 (75.8) | 5,049 (72.9) | 32,178 | 22,03% | |||
| C48 | Hypercholesterolemia | 105 (15.1) | 3,331 (2.9) | 800 (28.76) | 3,955 (23.2) | 1,069 (25.5) | 1,856 (26.8) | 11,116 | 7,61% | |||
| C52 | Diabetes | 161 (23.2) | 4,050 (3.5) | 836 (30.0) | 3,064 (17.9) | 1,009 (24.1) | 1,396 (20.2) | 10,516 | 7,20% | |||
| C37 | COPD | 49 (7.07) | 3,765 (3.29) | 433 (15.56) | 1,536 (9.00) | 611 (14.58) | 859 (12.40) | 7,253 | 4,96% | |||
| C27 | Ischemic heart disease | 85 (12.3) | 1,369 (1.2) | 691 (24.8) | 2,319 (13.6) | 1,137 (27.1) | 1,397 (20.2) | 6,998 | 4,79% | |||
| C29 | Cardiomyopathy with arrhythmia | 58 (8.4) | 1,284 (1.1) | 532 (19.1) | 1,855 (10.9) | 1,211 (28.9) | 1,574 (22.7) | 6,514 | 4,46% | |||
| C99 | Psychiatric conditions | 78 (11.26) | 4,592 (4.01) | 253 (9.09) | 734 (4.30) | 415 (9.90) | 400 (5.78) | 6,472 | 4,43% | |||
| C08 | Neoplasm in first line treatment | 119 (17.2) | 2,284 (2.0) | 436 (15.7) | 1,527 (8.9) | 431 (10.3) | 721 (10.4) | 5,518 | 3,78% | |||
| C33 | Cardiomyopathy without arrhyt. | 66 (9.5) | 1,358 (1.2) | 457 (16.4) | 1,628 (9.5) | 777 (18.5) | 992 (14.3) | 5,278 | 3,61% | |||
| C60 | Hypothyroidism | 25 (3.61) | 3,445 (3.01) | 154 (5.54) | 1,069 (6.26) | 194 (4.63) | 387 (5.59) | 5,274 | 3,61% | |||
| C59 | Neoplasm after 5 years | 17 (2.4) | 1,864 (1.6) | 184 (6.6) | 1,208 (7.1) | 441 (10.5) | 694 (10.0) | 4,408 | 3,02% | |||
| C20 | Chronic Heart Failure | 55 (7.94) | 528 (0.46) | 437 (15.71) | 1041 (6.10) | 892 (21.28) | 976 (14.09) | 3,929 | 2,69% | |||
| C57 | Neoplasm in follow-up. 1–5 yrs | 24 (3.5) | 1721 (1.5) | 166 (6.0) | 1028 (6.0) | 358 (8.5) | 559 (8.1) | 3,856 | 2,64% | |||
| C64 | Hashimoto's thyroiditis | 2 (0.29) | 2057 (1.80) | 34 (1.22) | 397 (2.33) | 31 (0.74) | 87 (1.26) | 2,608 | 1,79% | |||
| C02 | Chronic Renal failure | 47 (6.78) | 542 (0.47) | 253 (9.09) | 525 (3.08) | 377 (8.99) | 354 (5.11) | 2,098 | 1,44% | |||
| C25 | Cerebrovascular disease | 22 (3.17) | 255 (0.22) | 223 (8.02) | 484 (2.84) | 383 (9.14) | 458 (6.61) | 1,825 | 1,25% | |||
| C41 | Chronic hepatitis | 22 (3.17) | 1,086 (0.95) | 49 (1.76) | 376 (2.20) | 48 (1.15) | 129 (1.86) | 1,710 | 1,17% | |||
| C17 | Peripheral Artery Disease | 34 (4.91) | 372 (0.33) | 214 (7.69) | 515 (3.02) | 260 (6.20) | 274 (3.96) | 1,669 | 1,14% | |||
| C28 | Valvular heart disease | 20 (2.89) | 609 (0.53) | 130 (4.67) | 424 (2.48) | 224 (5.34) | 255 (3.68) | 1,662 | 1,14% | |||
| C38 | Epilepsy | 28 (4.04) | 645 (0.56) | 71 (2.55) | 172 ((1.01) | 68 (1.62) | 86 (1.24) | 1,070 | 0,73% | |||
| C46 | Inflammatory Bowel Diseases | 7 (1.01) | 735 (0.64) | 40 (1.44) | 168 (0.98) | 38 (0.91) | 44 (0.64) | 1,032 | 0,71% | |||
| C62 | Basedow and hyperthyroidism | 3 (0.43) | 698 (0.61) | 23 (0.83) | 163 (0.95) | 25 (0.60) | 33 (0.48) | 945 | 0,65% | |||
| C23 | Venous diseases | 16 (2.31) | 412 (0.36) | 60 (2.16) | 187 (1.10) | 95 (2.27) | 115 (1.66) | 885 | 0,61% | |||
| C47 | Alzheimer and Dementias | 2 (0.29) | 39 (0.03) | 103 (3.70) | 188 (1.10) | 217 (5.18) | 270 (3.90) | 819 | 0,56% | |||
| C40 | Rheumatoid arthritis | 2 (0.29) | 380 (0.33) | 38 (1.37) | 219 (1.28) | 46 (1.10) | 76 (1.10) | 761 | 0,52% | |||
| C32 | Parkinson's disease | 7 (1.01) | 76 (0.07) | 90 (3.24) | 185 (1.08) | 146 (3.48) | 136 (1.96) | 640 | 0,44% | |||
| C26 | Cirrhosis | 19 (2.74) | 283 (0.25) | 61 (2.19) | 149 (0.87) | 45 (1.07) | 71 (1.03) | 628 | 0,43% | |||
| C06 | HIV/AIDS | 10 (1.44) | 459 (0.40) | 11 (0.40) | 32 (0.19) | 1 (0.02) | 3 (0.04) | 516 | 0,35% | |||
| C01 | Transplanted | 24 (3.46) | 254 (0.22) | 29 (1.040) | 80 (0.47) | 10 (0.24) | 8 (0.12) | 405 | 0,28% | |||
| C44 | Psoriasis and psoriatic arthritis | 2 (0.29) | 268 (0.23) | 11 (0.40) | 44 (0.26) | 7 (0.17) | 7 (0.10) | 339 | 0,23% | |||
| C14 | Multiple sclerosis | 1 (0.14) | 282 (0.25) | 6 (0.22) | 34 (0.20) | 2 (0.05) | 6 (0.09) | 331 | 0,23% | |||
| C05 | Blood and Hematopoietic | 2 (0.29) | 222 (0.19) | 17 (0.61) | 21 (0.12) | 4 (0.10) | 9 (0.13) | 275 | 0,19% | |||
| C45 | Lupus erythematosus | 7 (1.01) | 106 (0.09) | 7 (0.25) | 26 (0.15) | 4 (0.10) | 5 (0.07) | 155 | 0,11% | |||
| C51 | Sjogren’ s disease | 0 (0) | 85 (0.07) | 2 (0.07) | 45 (0.26) | 9 (0.21) | 11 (0.16) | 152 | 0,10% | |||
| C21 | Systemic sclerosis | 0 (0) | 76 (0.07) | 9 (0.32) | 28 (0.16) | 3 (0.07) | 9 (0.13) | 125 | 0,09% | |||
| C15 | Chronic pancreatitis | 3 (0.43) | 38 (0.03) | 10 (0.36) | 31 (0.18) | 12 (0.29) | 20 (0.29) | 114 | 0,08% | |||
| C49 | Hyper and hypoparathyroidism | 0 (0) | 69 (0.06) | 2 (0.07) | 32 (0.19) | 3 (0.07) | 8 (0.12) | 114 | 0,08% | |||
| C22 | Ankylosing spondylitis | 0 (0) | 70 (0.06) | 2 (0.07) | 9 (0.05) | 2 (0.05) | 0 (0) | 83 | 0,06% | |||
| C39 | Myasthenia gravis | 3 (0.43) | 27 (0.02) | 11 (0.4) | 11 (0.06) | 11 (0.26) | 7 (0.10) | 70 | 0,05% | |||
| C36 | Addison’s disease | 1 (0.14) | 29 (0.03) | 1 (0.04) | 11 (0.06) | 3 (0.07) | 1 (0.01) | 46 | 0,03% | |||
| C04 | Acromegaly and gigantism | 1 (0.14) | 10 (0.01) | 3 (0.11) | 9 (0.05) | 3 (0.07 | 1 (0.01) | 27 | 0,02% | |||
| C24 | Cushing syndrome | 0 (0) | 15 (0.01) | 0 (0) | 1 (0.01) | 0 (0) | 0 (0) | 16 | 0,01% | |||